|
Volumn 334, Issue 7595, 2007, Pages 648-649
|
Erythropoiesis stimulating agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANTINEOPLASTIC AGENT;
CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR;
ERYTHROPOIETIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PLACEBO;
RECOMBINANT ERYTHROPOIETIN;
HEMOPOIETIC GROWTH FACTOR;
ANEMIA;
BLOOD TRANSFUSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG SAFETY;
EDITORIAL;
ERYTHROPOIESIS;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
META ANALYSIS;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SYSTEMATIC REVIEW;
TREATMENT OUTCOME;
TUMOR GROWTH;
DRUG CONTRAINDICATION;
DRUG EFFECT;
NEOPLASM;
ANEMIA;
ERYTHROPOIESIS;
HEMATOPOIETIC CELL GROWTH FACTORS;
HUMANS;
NEOPLASMS;
|
EID: 34247266733
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.39163.536852.80 Document Type: Editorial |
Times cited : (5)
|
References (0)
|